Biotech pharma

Convexia

Website

An AI-maximalist pharma platform. We use agents to buy drugs, run clinical trials, and sell for a profit. 10x faster and 20x leaner than incumbents. Sourcing Agent: Mines public/private databases and unstructured global data to surface overlooked preclinical candidates. Scientific Agent: Runs comp bio models (ESM-3, RFdiffusion, Boltz-2, AlphaF

Founded 2025Origin source ↗Checked 2026-09-15

Overview

An AI-maximalist pharma platform. We use agents to buy drugs, run clinical trials, and sell for a profit. 10x faster and 20x leaner than incumbents.

Sourcing Agent: Mines public/private databases and unstructured global data to surface overlooked preclinical candidates.

Scientific Agent: Runs comp bio models (ESM-3, RFdiffusion, Boltz-2, AlphaFold) to assess safety and efficacy in silico.

Commercial Agent: Analyzes FDA incentives, pricing dynamics, TAM, competitive landscape, and payer alignment.

Clinical Agent: Runs digital twin simulations, evaluates CRO/CMC risk, and builds trial plans to Phase 1.

PoS Agent: Evaluates the most critical factors that impact the likelihood of clinical trial success.

Built by 2 Stanford CS students who have built 3 startups together before.

Company description As recorded 2026-11-08

Founders & team

Ayaan Parikh

Founder/CEO

Building agents to find and acquire early-stage drug assets. Stanford CS + Bio Built 3 healthtech startups (telemedicine, addiction recovery, hydroponic systems). Published 4 papers on molecular dynamics. Biotech VC and consulting experience.

Founder profile As recorded 2026-09-15

Rahul Vijayan

Founder/CTO

Building agents to find and acquire early-stage drug assets. Stanford CS + Econ Built 3 healthtech startups (telemedicine, gamified recovery, hydroponic systems).

Founder profile As recorded 2026-09-15
4team members reported
Source-reported As recorded 2026-09-15

Founded 2025 · Source

Origins

Ayaan and Rahul met at an entrepreneurship conference in 8th grade and have been building together ever since. By the end of high school, they’d launched two startups. At Stanford, they built a third, recently acquired. Now they’re on their fourth venture - and this is the one they believe can be a unicorn.

Founder account As recorded 2026-09-15

News & product activity

Sources & observations

Y Combinator

Profile depthverified profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedSan Francisco, CA, USA
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 3 of 6 areas documented

Source-based assessment · automated evidence rules

The retained text does not establish product availability or customer use.

Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.

Stage definitions
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and modelsourced peoplesourced founding year